EGF Theramed Health Corp.
TMED
Rank in Stocks
#39133
EGF Theramed Health Corp. focuses on providing psychedelic-based therapies to... EGF Theramed Health Corp. focuses on providing psychedelic-based therapies to address various mental health challenges. The company's products are specifically utilized in the treatment of conditions such as intractable depression, anxiety disorders, post-traumatic stress disorder (PTSD), and general depression. Established in 2011, this firm operates from its main headquarters in Vancouver, Canada.
Share Price
$0.05137558
Last synced: 2026-06-26
Market Cap
$596.81K
Change (1 day)
0.00%
Change (1 year)
-32.40%
Country
CA
Trade EGF Theramed Health Corp. (TMED)
Category
Healthcare
EPS for EGF Theramed Health Corp. (TMED)
EPS as of 2026 TTM: 0
According to EGF Theramed Health Corp. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for EGF Theramed Health Corp. from 2026 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.48 | - |
US
|
|
| $1.79 | - |
AU
|
|
| $1.43 | - |
US
|
|
| $-1.43 | - |
US
|
|
| $-0.59 | - |
US
|
